Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Super Capacity Pump

By Drug Discovery Trends Editor | November 16, 2012

Copley Scientific has launched a super capacity pump, the SCP5, to efficiently meet requirements for high flow rate dry powder inhaler (DPI) testing, in accordance with USP and Ph.Eur. methodologies. The powerful, oil lubricated SCP5 generates flow rates up to 100 L/min (the limit required for all DPI testing) under the stable, sonic flow conditions necessary for robust aerodynamic particle size distribution (APSD) measurement, when used with all the pharmacopoeial specified cascade impactors. A quiet and space-efficient option for high flow rate generation, the SCP5 incorporates a flow control valve and regulated inlets that also enable testing of other types of orally inhaled and nasal drug products (OINDPs), for maximum flexibility.

Cascade impaction is used to measure the APSD of all OINDPs. Successful analysis relies on the application of a stable controlled air flow at an appropriate rate for the product, which for low resistance DPIs can be as high as 100 L/min. Of the pharmacopoeia specified impactors routinely used, the NGI has the highest flow resistance and therefore presents the greatest challenge in terms of ensuring the sonic flow regime that underpins flow stability.

The SCP5 shares the neat bench top design and robust engineering of the existing Copley Scientific  range of high performance, low maintenance, oil-free rotary-vane vacuum pumps that, together, span  the full range of testing requirements for OINDPs. With a 420 mm by 600 mm footprint and weighing in at 70 kg  it provides an alternative to the common practice of linking up two high capacity pumps to generate sonic flow conditions through the NGI at high flow rates. Two complete sets of vacuum inlets ( one regulated, one unregulated on either side of the pump) allow optimal positioning of the pump relative to other test equipment on the laboratory bench. The vacuum is drawn by a 1.5kW oil lubricated rotary vane pump that incorporates sound and vibration insulation, resulting in exceptionally low noise levels for its size and power. Quick release hatches allow for easy internal access for routine maintenance.

Copley Scientific


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE